# Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

> **NCT04693429** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 22 (actual)

## Conditions studied

- Safety
- Tolerability
- Ocular Surface
- Ocular Comfort

## Interventions

- **DRUG:** Bepotastine Besilate

## Key facts

- **NCT ID:** NCT04693429
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-24
- **Primary completion:** 2020-11-27
- **Final completion:** 2020-12-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693429, "Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04693429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*